{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T21:44:45Z","timestamp":1779399885231,"version":"3.53.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,11,18]],"date-time":"2012-11-18T00:00:00Z","timestamp":1353196800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s00066-012-0178-0","type":"journal-article","created":{"date-parts":[[2012,11,16]],"date-time":"2012-11-16T23:03:19Z","timestamp":1353106999000},"page":"26-32","source":"Crossref","is-referenced-by-count":15,"title":["Efficacy and toxicity of (chemo)radiotherapy for primary subglottic cancer","Wirksamkeit und Toxizit\u00e4t der (Chemo-)Radiotherapie bei prim\u00e4rem subglottischem Karzinom"],"prefix":"10.1007","volume":"189","author":[{"given":"M.","family":"Hata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Koike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Odagiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Minagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,11,18]]},"reference":[{"key":"178_CR1","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/MLG.0b013e31815a9ed3","volume":"118","author":"Boscolo-Rizzo","year":"2008","unstructured":"Boscolo-Rizzo P, Maronato F, Marchiori C et al (2008) Long-term quality of life after total laryngectomy and postoperative radiotherapy versus concurrent chemoradiotherapy for laryngeal preservation. Laryngoscope 118:300\u2013306","journal-title":"Laryngoscope"},{"key":"178_CR2","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1200\/JCO.1989.7.11.1748","volume":"7","author":"Calvert","year":"1989","unstructured":"Calvert AH, Newell DR, Gumbrell LA et al (1989) Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J Clin Oncol 7:1748\u20131756","journal-title":"J Clin Oncol"},{"key":"178_CR3","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","volume":"31","author":"Cox","year":"1995","unstructured":"Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31:1341\u20131346","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"178_CR4","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/00005537-199805000-00022","volume":"108","author":"Dahm","year":"1998","unstructured":"Dahm JD, Sessions DG, Paniello RC et al (1998) Primary subglottic cancer. Laryngoscope 108:741\u2013746","journal-title":"Laryngoscope"},{"key":"178_CR5","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s004050050217","volume":"257","author":"Ferlito","year":"2000","unstructured":"Ferlito A, Rinaldo A (2000) The pathology and management of subglottic cancer. Eur Arch Otorhinolaryngol 257:168\u2013173","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"178_CR6","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa031317","volume":"349","author":"Forastiere","year":"2003","unstructured":"Forastiere AA, Goepfert H, Maor M et al (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091\u20132098","journal-title":"N Engl J Med"},{"key":"178_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjoto.2005.05.004","volume":"27","author":"Garas","year":"2006","unstructured":"Garas J, McGuirt WF Sr (2006) Squamous cell carcinoma of the subglottis. Am J Otolaryngol 27:1\u20134","journal-title":"Am J Otolaryngol"},{"key":"178_CR8","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/0360-3016(91)90339-6","volume":"21","author":"Guedea","year":"1991","unstructured":"Guedea F, Parsons JT, Mendenhall WM et al (1991) Primary subglottic cancer: results of radical radiation therapy. Int J Radiat Oncol Biol Phys 21:1607\u20131611","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"178_CR9","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1517\/14656561003749256","volume":"11","author":"Haigentz","year":"2010","unstructured":"Haigentz M Jr, Silver CE, Hartl DM et al (2010) Chemotherapy regimens and treatment protocols for laryngeal cancer. Expert Opin Pharmacother 11:1305\u20131316","journal-title":"Expert Opin Pharmacother"},{"key":"178_CR10","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0196-0709(94)90130-9","volume":"15","author":"Hanna","year":"1994","unstructured":"Hanna EYN (1994) Subglottic cancer. Am J Otolaryngol 15:322\u2013328","journal-title":"Am J Otolaryngol"},{"key":"178_CR11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/000348947108000102","volume":"80","author":"Harrison","year":"1971","unstructured":"Harrison DF (1971) The pathology and management of subglottic cancer. Ann Otol Rhinol Laryngol 80:6\u201312","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"178_CR12","first-page":"143","volume":"Oncol","author":"Haylock","year":"1993","unstructured":"Haylock BJ, Deutsch GP (1993) Primary radiotherapy for subglottic carcinoma. Clin Oncol (R Coll Radiol) 5:143\u2013146","journal-title":"Clin"},{"key":"178_CR13","unstructured":"International Commission on Radiation Units and Measurements (ICRU) (1993) Prescribing, recording, and reporting photon beam therapy. ICRU report 50. ICRU, Washington DC"},{"key":"178_CR14","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457\u2013481","journal-title":"J Am Stat Assoc"},{"key":"178_CR15","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s00066-011-2186-x","volume":"187","author":"Kuhnt","year":"2011","unstructured":"Kuhnt T, Klockenbrink U, Knipping S et al (2011) Adjuvant low single dose cisplatin-based concurrent radiochemotherapy of oral cavity and oropharynx carcinoma: impact of extracapsular nodal spread on distant metastases. Strahlenther Onkol 187:292\u2013299","journal-title":"Strahlenther Onkol"},{"key":"178_CR16","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ijrobp.2009.01.058","volume":"76","author":"Lambert","year":"2010","unstructured":"Lambert L, Fortin B, Souli\u00e8res D et al (2010) Organ preservation with concurrent chemoradiation for advanced laryngeal cancer: are we succeeding? Int J Radiat Oncol Biol Phys 76:398\u2013402","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"178_CR17","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1093\/jjco\/hyq077","volume":"40","author":"Nakayama","year":"2010","unstructured":"Nakayama M, Hayakawa K, Okamoto M et al (2010) Phase I\/II trial of concurrent use of S-1 and radiation therapy for T2 glottic cancer. Jpn J Clin Oncol 40:921\u2013926","journal-title":"Jpn J Clin Oncol"},{"key":"178_CR18","first-page":"3497","volume":"27","author":"Niibe","year":"2007","unstructured":"Niibe Y, Nakayama M, Matsubayashi T et al (2007) Effectiveness of concurrent radiation therapy with UFT or TS-1 for T2N0 glottic cancer in Japan. Anticancer Res 27:3497\u20133500","journal-title":"Anticancer Res"},{"key":"178_CR19","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.anl.2007.02.004","volume":"34","author":"Nishimura","year":"2007","unstructured":"Nishimura G, Tsukuda M, Horiuchi C et al (2007) Concurrent chemoradiotherapy for T4 patients with hypopharyngeal and laryngeal squamous cell carcinomas. Auris Nasus Larynx 34:499\u2013504","journal-title":"Auris Nasus Larynx"},{"key":"178_CR20","first-page":"661","volume":"29","author":"Nishimura","year":"2009","unstructured":"Nishimura G, Tsukuda M, Mikami Y et al (2009) Efficacy of concurrent chemoradiotherapy for T1 and T2 laryngeal squamous cell carcinoma regarding organ preservation. Anticancer Res 29:661\u2013666","journal-title":"Anticancer Res"},{"key":"178_CR21","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0360-3016(01)02759-6","volume":"52","author":"Paisley","year":"2002","unstructured":"Paisley S, Warde PR, O\u2019Sullivan B et al (2002) Results of radiotherapy for primary subglottic squamous cell carcinoma. Int J Radiat Oncol Biol Phys 52:1245\u20131250","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"178_CR22","first-page":"1","volume":"142","author":"Pietrantoni","year":"1958","unstructured":"Pietrantoni L, Fior R (1958) Clinical and surgical problems of cancer of the larynx and hypopharynx; a review 570 consecutive cases operated on in the Ear, Nose and Throat Clinic of the University of Milan between 1948 and 1954, with special regard to the problem of metastases. Acta Otolaryngol Suppl 142:1\u201361","journal-title":"Acta Otolaryngol Suppl"},{"key":"178_CR23","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","volume":"92","author":"Pignon","year":"2009","unstructured":"Pignon JP, le Ma\u00eetre A, Maillard E et al (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 92:4\u201314","journal-title":"Radiother Oncol"},{"key":"178_CR24","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/jnci\/djp007","volume":"101","author":"Pointreau","year":"2009","unstructured":"Pointreau Y, Garaud P, Chapet S et al (2009) Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. J Natl Cancer Inst 101:498\u2013506","journal-title":"J Natl Cancer Inst"},{"key":"178_CR25","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00066-011-2262-2","volume":"187","author":"Rades","year":"2011","unstructured":"Rades D, Meyners T, Kazic N et al (2011) Comparison of radiochemotherapy alone to surgery plus radio(chemo)therapy for non-metastatic stage III\/IV squamous cell carcinoma of the head and neck: a matched-pair analysis. Strahlenther Onkol 187:541\u2013547","journal-title":"Strahlenther Onkol"},{"key":"178_CR26","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s00066-011-1139-8","volume":"187","author":"Rades","year":"2011","unstructured":"Rades D, Seibold ND, Gebhard MP et al (2011) Prognostic factors (including HPV status) for irradiation of locally advanced squamous cell carcinoma of the head and neck (SCCHN). Strahlenther Onkol 187:626\u2013632","journal-title":"Strahlenther Onkol"},{"key":"178_CR27","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s004050000275","volume":"257","author":"Santoro","year":"2000","unstructured":"Santoro R, Turelli M, Polli G (2000) Primary carcinoma of the subglottic larynx. Eur Arch Otorhinolaryngol 257:548\u2013551","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"178_CR28","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00066-011-1111-7","volume":"187","author":"Semrau","year":"2011","unstructured":"Semrau R, Temming S, Preuss SF et al (2011) Definitive radiochemotherapy of advanced head and neck cancer with carboplatin and paclitaxel: a phase II study. Strahlenther Onkol 187:645\u2013650","journal-title":"Strahlenther Onkol"},{"key":"178_CR29","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/0002-9610(82)90422-6","volume":"144","author":"Shaha","year":"1982","unstructured":"Shaha AR, Shah JP (1982) Carcinoma of the subglottic larynx. Am J Surg 144:456\u2013458","journal-title":"Am J Surg"},{"key":"178_CR30","first-page":"751","volume":"Oncol","author":"Smee","year":"2008","unstructured":"Smee RI, Williams JR, Bridger GP (2008) The management dilemmas of invasive subglottic carcinoma. Clin Oncol (R Coll Radiol) 20:751\u2013756","journal-title":"Clin"},{"key":"178_CR31","doi-asserted-by":"crossref","unstructured":"Sobin LH, Gospodarowicz MK, Wittekind C (2010) TNM classification of malignant tumours. 7th edn., Wiley-Blackwell, Hoboken","DOI":"10.1002\/9780471420194.tnmc29"},{"key":"178_CR32","first-page":"612","volume":"4","author":"Stell","year":"1975","unstructured":"Stell PM, Tobin KE (1975) The behavior of cancer affecting the subglottic space. Can J Otolaryngol 4:612\u2013617","journal-title":"Can J Otolaryngol"},{"key":"178_CR33","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1017\/S0022215106000880","volume":"120","author":"Taguchi","year":"2006","unstructured":"Taguchi T, Tsukuda M, Mikami Y et al (2006) Concurrent chemoradiotherapy with carboplatin and uracil-tegafur in patients with stage two (T2N0M0) squamous cell carcinoma of the glottic larynx. J Laryngol Otol 120:478\u2013481","journal-title":"J Laryngol Otol"},{"key":"178_CR34","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1080\/00016480500401019","volume":"126","author":"Taguchi","year":"2006","unstructured":"Taguchi T, Tsukuda M, Mikami Y et al (2006) Concurrent chemoradiotherapy with cisplatin, 5-fluorouracil, methotrexate, and leucovorin in patients with advanced resectable squamous cell carcinoma of the larynx and hypopharynx. Acta Otolaryngol 126:408\u2013413","journal-title":"Acta Otolaryngol"},{"key":"178_CR35","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1177\/000348946407300301","volume":"73","author":"Welsh","year":"1964","unstructured":"Welsh LW (1964) The normal human laryngeal lymphatics. Ann Otol Rhinol Laryngol 73:569\u2013582","journal-title":"Ann Otol Rhinol Laryngol"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-012-0178-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-012-0178-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-012-0178-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T18:34:32Z","timestamp":1562351672000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-012-0178-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,18]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["178"],"URL":"https:\/\/doi.org\/10.1007\/s00066-012-0178-0","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,18]]}}}